HIV/AIDS
Oct 03, 2022
HIV seroconversions among patients prescribed PrEP were driven by poor adherence, with many patients who acquired HIV reporting low self-perceived risk for HIV. “PrEP is highly effective when...
Sep 27, 2022
Pre-exposure prophylaxis (PrEP) for HIV prevention has been shown to be an effective strategy and is indicated for people at increased risk for infection from sexual contact or injection drug use. “...
Sep 16, 2022
For a study, researchers sought to understand that contrary to those without HIV, women with HIV had a higher rate of unplanned pregnancies. To lower the rate of perinatal HIV transmission globally, t...
Sep 15, 2022
As diabetes rates continue to rise in patients with HIV, research is needed to address the modifiable and HIV-related risk factors related to this increase. “Adults with HIV have a greater ri...
Sep 13, 2022
There is no known resistance to the individual components of the HIV medication bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF). The effectiveness of B/F/TAF has been demonstrated in several...
Sep 13, 2022
The purpose of this study was to compare the efficacy and safety results for AMBER and EMERALD patients with and without baseline neurological and/or psychiatric comorbidities (NPCs). Both the AMBER a...
Sep 13, 2022
ViiV Healthcare and Janssen backed a single-patient request program where doctors could seek compassionate use of oral and long-acting (LA) cabotegravir + rilpivirine for persons living with HIV-1. ...
Sep 13, 2022
Human immunodeficiency virus (HIV's) effect on how one age is controversial and poorly understood. Researchers compared the occurrence of 4 age-related non-communicable diseases in those with and with...
Sep 13, 2022
Obesity and the diseases caused by being overweight are common among those with the Human immunodeficiency virus (HIV). Researcher’s study's overarching objective was to identify and assess characte...
Sep 13, 2022
Blood-borne viruses (BBVs) cause significant morbidity and mortality worldwide. For populations at high risk of BBVs but less inclined to seek out primary care, Emergency departments (EDs) provide an ...
Jun 17, 2022
Providers should not continue prescribing opioids to patients with HIV when risks outweigh benefits, but they need to factor the risks of stopping opioids into the equation. “There are specif...
May 16, 2022
BACKGROUND Recent reports have shown an increased incidence of Hodgkin lymphoma (HL) in patients treated with antiretroviral therapy (ART) for human immunodeficiency virus (HIV) infection. This report...
May 16, 2022
In 2020 the number of displaced people worldwide reached 41.3 million (IOM, 2020). Among them, are many migrants and refugees at risk of sexual and gender-based violence (SGBV). Healthcare providers h...
May 12, 2022
A study published in AIDS and Behavior identified social and structural factors that impacted PrEP uptake, but also found that women facing barriers to PrEP still initiated it. “Nearly 20% of...
May 09, 2022
There is stark global inequity in health research in terms of where studies happen, who leads the research and the ultimate beneficiaries of the results generated. Despite significant efforts made, li...
May 09, 2022
Microglia are implicated in Alzheimer's Disease (AD) pathogenesis. In a middle-aged cohort enriched for neuroinflammation, we asked whether microgliosis was related to neocortical amyloid beta (A[Form...
Apr 25, 2022
SLC2A1 mediates glucose cellular uptake; key to appropriate immune function. Our previous work has shown efavirenz and lopinavir exposure inhibits T cell and macrophage responses, to known agonists, l...
Apr 18, 2022
Kaposi Sarcoma (KS) is endemic in several countries in Southern and Eastern Africa, relatively rare worldwide but a leading cancer among people living with HIV. KS has always been more common in adult...
Apr 08, 2022
While antiretroviral therapy has changed the paradigm for patients with HIV, these individuals still experience an increased risk for comorbid conditions, including kidney disease. “Antiretro...
